Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
暂无分享,去创建一个
F. Behm | M. Weiner | A. Cantor | M. Wharam | R. Marcus | J. Ternberg | B. Leventhal | M. Brecher | A. Chauvenet | M. Wharam | B. G. Leventhal | A B Cantor | R B Marcus | M A Weiner | Fred G. Behm
[1] N. Day,et al. Leukemia following Hodgkin's disease. , 1990, The New England journal of medicine.
[2] J. Connors,et al. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program. , 1988, Seminars in hematology.
[3] J. Bertino,et al. Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Wannenmacher,et al. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies. , 1988, Bulletin du cancer.
[5] S. Donaldson,et al. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] E. Jaffe,et al. Twenty years of MOPP therapy for Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A. Santoro,et al. Second acute leukemia and other malignancies following treatment for Hodgkin's disease. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Coleman. Secondary malignancy after treatment of Hodgkin's disease: an evolving picture. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] P. Gobbi,et al. Reevaluation of prognostic significance of symptoms in Hodgkin's disease , 1985, Cancer.
[10] M. Gospodarowicz,et al. Prognostic groups for management of localized Hodgkin's disease. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] S. Rosenberg,et al. Late relapse among patients treated for Hodgkin's disease. , 1985, Annals of internal medicine.
[12] H. Kaplan,et al. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. , 1984, International journal of radiation oncology, biology, physics.
[13] F. Mandelli,et al. Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease. , 1983, Cancer treatment reports.
[14] C. Coltman,et al. Comparison of adriamycin‐containing chemotherapy (MOP‐BAP) with MOPP‐bleomycin in the management of advanced Hodgkin‐s disease a southwest oncology group study , 1983, Cancer.
[15] M. Greenberg,et al. Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation. , 1982, Cancer treatment reports.
[16] A. Bartolucci,et al. Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group. , 1982, Cancer treatment reports.
[17] C. Coleman. Leukemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease , 1982 .
[18] J H Goldie,et al. Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982, Cancer treatment reports.
[19] I. Mcdougall,et al. Functional hyposplenia after splenic irradiation for Hodgkin's disease. , 1982, Annals of internal medicine.
[20] D. Ilstrup,et al. Prognostic significance of mediastinal mass in childhood Hodgkin's disease. , 1982, Cancer treatment reports.
[21] C. Bloomfield,et al. Prognostic significance of mediastinal involvement in Hodgkin's disease treated with curative radiotherapy , 1980, Cancer.
[22] R. Hoppe,et al. Prognostic factors in pathological stage IIIA Hodgkin's disease , 1980, Cancer.
[23] S. Hellman,et al. Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease? , 1980, International journal of radiation oncology, biology, physics.
[24] V. Devita,et al. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. , 1980, Annals of internal medicine.
[25] S. Donaldson,et al. Bacterial infections in pediatric Hodgkin's disease. Relationship to radiotherapy, chemotherapy and splenectomy , 1978, Cancer.
[26] G. Bonadonna,et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP , 1975, Cancer.
[27] S. Murphy,et al. Hodgkin's disease and the non-Hodgkin's lymphomas in childhood. , 1974, Seminars in oncology.
[28] H. Kaplan,et al. Growth retardation in children after megavoltage irradiation of the spine , 1973, Cancer.
[29] R. L. Warkel,et al. Letter: Hodgkin's disease in children. , 1973, Lancet.
[30] V. Devita,et al. Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1970, Annals of internal medicine.
[31] R. Gross,et al. Hazard of overwhelming infection after splenectomy in childhood. , 1967, The New England journal of medicine.